speb/financial-data huggingface dataset:
Financial ratios for AXGN — annual report dated 2023-12-31
Total revenue: 159012000
Gross profit: 121869000
Operating income: -21462000
Net income: -21716000
Capital expenditures: 13872000
Operating cash flow: -5716000
Depreciation & amortization: 5553000
Net tangible assets: 91134000
Owner earnings: -30035000
Return on net tangible assets (%): -32.956964469901465
Buffett classification: The Gruesome
Stock price: 6.83
Shares outstanding: 53177824
Book value: 95665000
P/B ratio: 3.796629257513197
Market cap (USD): 363204537.92
Debt to equity: 0.7243192390111326
Current ratio: 2.892014459415051
Quick ratio: 2.1355241537955965
Interest coverage ratio: -7.57037037037037
COGS to revenue (%): 23.35861444419289
R&D to revenue (%): 17.19304203456343
SG&A to revenue (%): 72.9454380801449
Free cash flow (dilution-adjusted): -35052000
Buyback yield (%): 0
Retained earnings: -281296000
Inventory turnover: 1.6135099913119026
Receivables turnover: 6.32329900186901
Capitalized R&D asset: 44509090
ROCI (R&D-adjusted, %): -5.584634058377988
Rosenberg metric: 0.50961876146252
FCF margin (%): -22.043619349483055
Revenue growth (%): 14.74051838596086
Rule of 40 score: -7.303100963522196
Financial ratios for AXGN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.02
Shares outstanding: 53177824
Market cap (USD): 745553092.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AXGN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.48
Shares outstanding: 53177824
Market cap (USD): 876370539.52
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AXGN — annual report dated 2024-12-31
Total revenue: 187338000
Gross profit: 141977000
Operating income: -3287000
Net income: -9964000
Capital expenditures: 3101000
Operating cash flow: 4535000
Depreciation & amortization: 7837000
Net tangible assets: 98328000
Owner earnings: -5228000
Return on net tangible assets (%): -5.316898543649825
Buffett classification: The Gruesome
Stock price: 16.48
Shares outstanding: 53177824
Book value: 103907000
P/B ratio: 8.434181908052393
Market cap (USD): 876370539.52
Debt to equity: 0.6610334241196455
Current ratio: 3.241326363933355
Quick ratio: 2.157268866383535
Interest coverage ratio: -0.400560565439922
COGS to revenue (%): 24.21345375737971
R&D to revenue (%): 14.821872764735398
SG&A to revenue (%): 62.71925610394047
Free cash flow (dilution-adjusted): -15895000
Buyback yield (%): 0
Retained earnings: -291260000
Inventory turnover: 1.3669951481180123
Receivables turnover: 7.7717485998755444
Capitalized R&D asset: 54541040
ROCI (R&D-adjusted, %): -1.0678249368002255
Rosenberg metric: 0.7355060536230293
FCF margin (%): -8.484664083101134
Revenue growth (%): 17.813749905667496
Rule of 40 score: 9.329085822566363
Financial ratios for AXGN — quarterly report dated 2025-03-31
Total revenue: 48560000
Gross profit: 34933000
Operating income: -1661000
Net income: -3834000
Capital expenditures: 256000
Operating cash flow: -13179000
Depreciation & amortization: 1882000
Net tangible assets: 99484000
Owner earnings: -2208000
Return on net tangible assets (%): -2.219452374251136
Buffett classification: The Gruesome
Stock price: 18.5
Shares outstanding: 53177824
Book value: 105365000
P/B ratio: 9.336969050443695
Market cap (USD): 983789744
Debt to equity: 0.6495800313196982
Current ratio: 4.280064382616693
Quick ratio: 2.647321223269717
Interest coverage ratio: -0.7382222222222222
COGS to revenue (%): 28.062191103789125
R&D to revenue (%): 12.54324546952224
SG&A to revenue (%): 62.81507413509061
Free cash flow (dilution-adjusted): -16749000
Buyback yield (%): 0
Retained earnings: -295094000
Inventory turnover: 0.3838159080666967
Receivables turnover: 1.8467389237497622
Capitalized R&D asset: 6091000
ROCI (R&D-adjusted, %): 1.3293742024955082
FCF margin (%): -34.491350906095555
Rule of 40 score: -34.491350906095555
Financial ratios for AXGN — quarterly report dated 2025-06-30
Total revenue: 56662000
Gross profit: 42018000
Operating income: 1672000
Net income: 579000
Capital expenditures: 722000
Operating cash flow: 7730000
Depreciation & amortization: 1820000
Net tangible assets: 106161000
Owner earnings: 1677000
Return on net tangible assets (%): 1.5796761522593041
Capex to operating income (%): 43.18181818181818
Buffett classification: The Good
Stock price: 10.85
P/E ratio: 249.12754335060447
Shares outstanding: 53177824
Book value: 112276000
P/B ratio: 5.138937888774092
Market cap (USD): 576979390.4
Debt to equity: 0.6073248067262816
Current ratio: 4.140072057646117
Quick ratio: 2.667934347477982
Interest coverage ratio: 0.8457258472432979
COGS to revenue (%): 25.844481310225547
R&D to revenue (%): 12.094525431506124
SG&A to revenue (%): 59.11016201334227
Free cash flow (dilution-adjusted): 1452000
Buyback yield (%): 0
Retained earnings: -294515000
Inventory turnover: 0.3982161309620928
Receivables turnover: 2.021549109850512
Capitalized R&D asset: 10933970
ROCI (R&D-adjusted, %): 2.19967607936813
Rosenberg metric: 1.163191594155311
FCF margin (%): 2.5625639758568353
Revenue growth (%): 16.684514003294893
Rule of 40 score: 19.24707797915173
Financial ratios for AXGN — quarterly report dated 2025-09-30
Total revenue: 60082000
Gross profit: 45993000
Operating income: 1912000
Net income: 708000
Capital expenditures: 1520000
Operating cash flow: 3223000
Depreciation & amortization: 1840000
Net tangible assets: 114372000
Owner earnings: 1028000
Return on net tangible assets (%): 0.8988213898506627
Capex to operating income (%): 79.49790794979079
Buffett classification: The Gruesome
Stock price: 17.84
P/E ratio: 334.9902472316384
Shares outstanding: 53177824
Book value: 120805000
P/B ratio: 7.853088697984355
Market cap (USD): 948692380.16
Debt to equity: 0.5621787177683043
Current ratio: 4.086546700942588
Quick ratio: 2.6376392459297344
Interest coverage ratio: 1.0882185543540126
COGS to revenue (%): 23.449618854232547
R&D to revenue (%): 12.59112546186878
SG&A to revenue (%): 60.77693818448121
Free cash flow (dilution-adjusted): -4066000
Buyback yield (%): 0
Retained earnings: -293807000
Inventory turnover: 0.3471821788521722
Receivables turnover: 1.9522989439480098
Capitalized R&D asset: 14166540
ROCI (R&D-adjusted, %): 1.3036560525498786
Rosenberg metric: 0.5800379395885014
FCF margin (%): -6.767417862254918
Revenue growth (%): 6.0357911828032895
Rule of 40 score: -0.7316266794516286
Financial ratios for AXGN — quarterly report dated 2025-12-31
Total revenue: 59904000
Gross profit: 44409000
Operating income: -9772000
Net income: -13156000
Capital expenditures: 1247000
Operating cash flow: 3038000
Depreciation & amortization: 2966000
Net tangible assets: 122097000
Owner earnings: -11437000
Return on net tangible assets (%): -9.367142517834182
Buffett classification: The Gruesome
Stock price: 32.73
Shares outstanding: 53177824
Book value: 128847000
P/B ratio: 13.508348502642667
Market cap (USD): 1740510179.5199997
Debt to equity: 0.5248783440825164
Current ratio: 5.1121582611648835
Quick ratio: 3.3133384275768383
Interest coverage ratio: -5.688009313154831
COGS to revenue (%): 25.866386217948715
R&D to revenue (%): 20.65972222222222
SG&A to revenue (%): 69.78665865384616
Free cash flow (dilution-adjusted): -15531000
Buyback yield (%): 0
Retained earnings: -306963000
Inventory turnover: 0.36568097609326694
Receivables turnover: 2.2891207153502235
Capitalized R&D asset: 19706040
ROCI (R&D-adjusted, %): -2.9046177515693996
Rosenberg metric: -0.2093853271645737
FCF margin (%): -25.926482371794872
Revenue growth (%): -0.29626177557338307
Rule of 40 score: -26.222744147368257
Financial ratios for AXGN — annual report dated 2025-12-31
Total revenue: 225208000
Gross profit: 167353000
Operating income: -7849000
Net income: -15703000
Capital expenditures: 3745000
Operating cash flow: 812000
Depreciation & amortization: 8508000
Net tangible assets: 122097000
Owner earnings: -10940000
Return on net tangible assets (%): -8.96008910947853
Buffett classification: The Gruesome
Stock price: 32.73
Shares outstanding: 53177824
Book value: 128847000
P/B ratio: 13.508348502642667
Market cap (USD): 1740510179.5199997
Debt to equity: 0.5248783440825164
Current ratio: 5.1121582611648835
Quick ratio: 3.3133384275768383
Interest coverage ratio: -1.019085951700857
COGS to revenue (%): 25.689584739440875
R&D to revenue (%): 14.60205676530141
SG&A to revenue (%): 63.19358104507833
Free cash flow (dilution-adjusted): -34894000
Buyback yield (%): 0
Retained earnings: -306963000
Inventory turnover: 1.3653741769523045
Receivables turnover: 8.605907753448736
Capitalized R&D asset: 60510760
ROCI (R&D-adjusted, %): -1.6603402843119115
Rosenberg metric: 0.9138905895487449
FCF margin (%): -15.494120990373345
Revenue growth (%): 20.21479891959987
Rule of 40 score: 4.7206779292265235
Financial ratios for AZS.V — annual report dated 2021-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.15079365079365079
Shares outstanding: 114136347
Market cap (USD): 17211036.45238095
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AZS.V — annual report dated 2022-08-31
Total revenue: 0
Operating income: -445687.0229007633
Net income: -451801.5267175572
Capital expenditures: 1144438.93129771
Operating cash flow: -351725.95419847325
Net tangible assets: 5356307.633587786
Owner earnings: -1596240.4580152673
Return on net tangible assets (%): -29.801134796771677
Buffett classification: The Gruesome
Stock price: 0.18320610687022898
Shares outstanding: 114136347
Book value: 5356307.633587786
P/B ratio: 3.903897463830544
Market cap (USD): 20910475.78625954
Debt to equity: 0
Current ratio: 8.245333390286616
Quick ratio: 8.245333390286616
Free cash flow (dilution-adjusted): -1645564.1221374045
Buyback yield (%): 0
Retained earnings: -3252272.5190839693
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.320788374924447
Rule of 40 score: 0
Financial ratios for AZS.V — annual report dated 2023-08-31
Total revenue: 0
Operating income: -1198797.7777777778
Net income: -1193176.2962962962
Capital expenditures: 1095680
Operating cash flow: -371624.44444444444
Net tangible assets: 6036380.740740741
Owner earnings: -2288856.296296296
Return on net tangible assets (%): -37.91769264732338
Buffett classification: The Gruesome
Stock price: 0.274074074074074
Shares outstanding: 114136347
Book value: 6036380.740740741
P/B ratio: 5.182213476213487
Market cap (USD): 31281813.622222215
Debt to equity: 0.012437671138236623
Current ratio: 0.8977002590881167
Quick ratio: 0.8977002590881167
Interest coverage ratio: -1193.4933628318586
Free cash flow (dilution-adjusted): -2239728.148148148
Buyback yield (%): 0
Retained earnings: -4349085.185185185
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.8595454671514
Rule of 40 score: 0
Financial ratios for AZS.V — annual report dated 2024-08-31
Total revenue: 0
Gross profit: 0
Operating income: -527820
Net income: -2454780.7407407407
Capital expenditures: 770581.4814814815
Operating cash flow: -349378.5185185185
Depreciation & amortization: 0
Net tangible assets: 4974671.851851852
Owner earnings: -3225362.222222222
Return on net tangible assets (%): -64.83567797585607
Buffett classification: The Gruesome
Stock price: 0.2518518518518518
Shares outstanding: 114136347
Book value: 4974671.851851852
P/B ratio: 5.77836110835228
Market cap (USD): 28745450.355555553
Debt to equity: 0
Current ratio: 1.066380810925245
Quick ratio: 1.066380810925245
Interest coverage ratio: -46.66996332198061
Free cash flow (dilution-adjusted): -1295665.1851851852
Buyback yield (%): 0
Retained earnings: -6803865.925925925
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.610147075399874
Rule of 40 score: 0
Financial ratios for AZS.V — quarterly report dated 2024-11-30
Gross profit: 0
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 0.31428571428571433
Shares outstanding: 114136347
Market cap (USD): 35871423.342857145
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AZS.V — quarterly report dated 2025-02-28
Total revenue: 0
Gross profit: 0
Operating income: -123085.41666666667
Net income: -64846.52777777778
Capital expenditures: 629229.8611111111
Operating cash flow: -44080.555555555555
Depreciation & amortization: 0
Net tangible assets: 7947027.083333334
Owner earnings: -694076.3888888889
Return on net tangible assets (%): -8.733786630028227
Buffett classification: The Gruesome
Stock price: 0.22916666666666669
Shares outstanding: 114136347
Book value: 7947027.083333333
P/B ratio: 3.291324656783342
Market cap (USD): 26156246.187500004
Debt to equity: 0
Current ratio: 82.02912764908821
Quick ratio: 82.02912764908821
Free cash flow (dilution-adjusted): -673310.4166666667
Buyback yield (%): 0
Retained earnings: -7008531.25
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.548823420078735
Rule of 40 score: 0
Financial ratios for AZS.V — quarterly report dated 2025-05-31
Total revenue: 0
Operating income: -109249.27536231885
Net income: -188258.69565217392
Capital expenditures: 541684.0579710145
Operating cash flow: -194912.3188405797
Net tangible assets: 8574687.681159422
Owner earnings: -729942.7536231885
Return on net tangible assets (%): -8.512761989303028
Buffett classification: The Gruesome
Stock price: 0.19565217391304351
Shares outstanding: 114136347
Book value: 8574687.681159422
P/B ratio: 2.6042959514560424
Market cap (USD): 22331024.413043484
Debt to equity: 0
Current ratio: 32.90924316045792
Quick ratio: 32.90924316045792
Free cash flow (dilution-adjusted): -736596.3768115942
Buyback yield (%): 0
Retained earnings: -7501508.695652175
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2740904324989568
Rule of 40 score: 0
Financial ratios for AZS.V — annual report dated 2025-08-31
Total revenue: 0
Gross profit: -9015.328467153284
Operating income: -1028805.8394160583
Net income: -953829.1970802919
Capital expenditures: 2304309.4890510947
Operating cash flow: -331382.4817518248
Depreciation & amortization: 9015.328467153284
Net tangible assets: 9465283.21167883
Owner earnings: -3249123.3576642335
Return on net tangible assets (%): -34.3267421058809
Buffett classification: The Gruesome
Stock price: 0.23357664233576642
Shares outstanding: 114136347
Book value: 9465283.21167883
P/B ratio: 2.8165649251610074
Market cap (USD): 26659584.700729925
Debt to equity: 0.01611721606072071
Current ratio: 15.976878779015406
Quick ratio: 15.976878779015406
Interest coverage ratio: -331.4046555372678
Free cash flow (dilution-adjusted): -3248854.01459854
Buyback yield (%): 0
Retained earnings: -7658368.613138686
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.747590042055833
Rule of 40 score: 0
Financial ratios for AZS.V — quarterly report dated 2025-08-31
Total revenue: 0
Operating income: -117428.46715328467
Net income: -102104.37956204379
Capital expenditures: 598300.7299270072
Operating cash flow: 69.34306569343065
Net tangible assets: 9465283.21167883
Owner earnings: -700405.109489051
Return on net tangible assets (%): -7.399726915987569
Buffett classification: The Gruesome
Stock price: 0.23357664233576642
Shares outstanding: 114136347
Book value: 9465283.21167883
P/B ratio: 2.8165649251610074
Market cap (USD): 26659584.700729925
Debt to equity: 0.01611721606072071
Current ratio: 15.976878779015406
Quick ratio: 15.976878779015406
Interest coverage ratio: -37.826710557253705
Free cash flow (dilution-adjusted): -608048.905109489
Buyback yield (%): 0
Retained earnings: -7658368.613138686
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2267358678162879
Rule of 40 score: 0
Financial ratios for AZS.V — quarterly report dated 2025-11-30
Total revenue: 0
Gross profit: -13233.57142857143
Operating income: -530783.5714285715
Net income: -490525.00000000006
Capital expenditures: 441822.1428571429
Operating cash flow: -19370.714285714286
Depreciation & amortization: 13233.57142857143
Net tangible assets: 10061432.142857144
Owner earnings: -919113.5714285716
Return on net tangible assets (%): -9.13501734523025
Buffett classification: The Gruesome
Stock price: 0.5285714285714286
Shares outstanding: 114136347
Book value: 10061432.142857144
P/B ratio: 5.996085957657973
Market cap (USD): 60329211.98571429
Debt to equity: 0.014032012625297236
Current ratio: 28.440838144740923
Quick ratio: 28.440838144740923
Interest coverage ratio: -123.60229540918164
Free cash flow (dilution-adjusted): -864507.8571428572
Buyback yield (%): 0
Retained earnings: -7984785.714285715
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.226674420547898
Rule of 40 score: 0
Financial ratios for BILN.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.02608108108108108
Shares outstanding: 12780373
Market cap (USD): 333325.94445945945
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BILN.L — annual report dated 2022-12-31
Total revenue: 104354216.86746989
Gross profit: 42574698.79518072
Operating income: 7121686.746987952
Net income: 5703614.457831326
Capital expenditures: 5021686.746987952
Operating cash flow: 7959036.144578313
Depreciation & amortization: 2462650.6024096385
Net tangible assets: 41381927.71084338
Owner earnings: 3144578.3132530125
Return on net tangible assets (%): 7.598916935976942
Capex to operating income (%): 70.51260362036881
Buffett classification: The Good
Stock price: 0.027590361445783133
P/E ratio: 0.0618230971060414
Shares outstanding: 12780373
Book value: 41381927.71084337
P/B ratio: 0.008520992858182667
Market cap (USD): 352615.1104819277
Debt to equity: 0.07834745392610709
Current ratio: 1.722829467697503
Quick ratio: 1.574691193459522
Effective tax rate (%): 18.785383427689144
Interest coverage ratio: 62.22105263157894
COGS to revenue (%): 59.20174567621862
SG&A to revenue (%): 5.532592883367584
Free cash flow (dilution-adjusted): 1546987.9518072288
Buyback yield (%): 0
Retained earnings: 38336144.578313254
Inventory turnover: 15.38002399520096
Receivables turnover: 10.685171477917594
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.48598375687713
FCF margin (%): 1.4824393285150204
Rule of 40 score: 1.4824393285150204
Financial ratios for BILN.L — annual report dated 2023-12-31
Total revenue: 167715189.8734177
Gross profit: 68750632.9113924
Operating income: 16767088.607594935
Net income: 13069620.253164556
Capital expenditures: 3181012.658227848
Operating cash flow: 20187341.7721519
Depreciation & amortization: 2803797.46835443
Net tangible assets: 60554430.37974683
Owner earnings: 12692405.063291138
Return on net tangible assets (%): 20.960324428278774
Capex to operating income (%): 18.971765061150535
Buffett classification: The Great
Stock price: 0.04987341772151898
P/E ratio: 0.0487696558062954
Shares outstanding: 12780373
Book value: 60554430.37974684
P/B ratio: 0.010526081696559218
Market cap (USD): 637400.8812658227
Debt to equity: 0.03758518332706216
Current ratio: 1.847163071850529
Quick ratio: 1.7930347575216374
Effective tax rate (%): 22.8786973409023
Interest coverage ratio: 161.53658536585365
COGS to revenue (%): 59.00750971734783
Free cash flow (dilution-adjusted): 15329113.924050633
Buyback yield (%): 0
Retained earnings: 51521518.98734177
Inventory turnover: 49.60786802030457
Receivables turnover: 6.24593409701598
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.240091463414632
FCF margin (%): 9.139967545945131
Revenue growth (%): 60.71721383949094
Rule of 40 score: 69.85718138543606
Financial ratios for BILN.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 66278750
Buffett classification: The Gruesome
Stock price: 0.057374999999999995
Shares outstanding: 12780373
Book value: 66278750
P/B ratio: 0.011063484161590252
Market cap (USD): 733273.9008749999
Debt to equity: 0.030948833525074024
Current ratio: 2.3797234562971097
Quick ratio: 2.269804822043628
Buyback yield (%): 0
Retained earnings: 56925000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BILN.L — annual report dated 2024-12-31
Total revenue: 141326250
Gross profit: 65741250
Operating income: 12526250
Net income: 10340000
Capital expenditures: 5842500
Operating cash flow: 10887500
Depreciation & amortization: 2925000
Net tangible assets: 66278750
Owner earnings: 7422500
Return on net tangible assets (%): 11.198913678969504
Capex to operating income (%): 46.64205169144796
Buffett classification: The Good
Stock price: 0.057374999999999995
P/E ratio: 0.07091623799564796
Shares outstanding: 12780373
Book value: 66278750
P/B ratio: 0.011063484161590252
Market cap (USD): 733273.9008749999
Debt to equity: 0.030948833525074024
Current ratio: 2.3797234562971097
Quick ratio: 2.269804822043628
Effective tax rate (%): 23.50656556315887
Interest coverage ratio: 133.61333333333334
COGS to revenue (%): 53.48263326876642
Free cash flow (dilution-adjusted): 3297500
Buyback yield (%): 0
Retained earnings: 56925000
Inventory turnover: 27.460490463215258
Receivables turnover: 8.23219746614242
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.253193760545436
FCF margin (%): 2.3332537302871903
Revenue growth (%): -15.734376768934668
Rule of 40 score: -13.401123038647478
Financial ratios for BILN.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.05301369863013698
Shares outstanding: 12780373
Market cap (USD): 677534.8426027397
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BKKT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 212.75
Shares outstanding: 44706924
Market cap (USD): 9511398081
Buyback yield (%): 0.8887231853838334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BKKT — annual report dated 2022-12-31
Total revenue: 56224000
Gross profit: 54567000
Operating income: -177319000
Net income: -578105000
Capital expenditures: 30543000
Operating cash flow: -117597000
Depreciation & amortization: 25350000
Net tangible assets: 24578000
Owner earnings: -583298000
Return on net tangible assets (%): -2373.2525022377736
Buffett classification: The Gruesome
Stock price: 29.75
Shares outstanding: 44706924
Book value: 336074000
P/B ratio: 3.9575539583544104
Market cap (USD): 1330030989
Debt to equity: 0.07860173652231355
Current ratio: 3.5435639158136962
Quick ratio: 3.5435639158136962
COGS to revenue (%): 2.947140011383039
SG&A to revenue (%): 361.10024188958454
Free cash flow (dilution-adjusted): -180254000
Buyback yield (%): 0.1944315599702166
Retained earnings: -676447000
Receivables turnover: 2.221765589188335
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -48.79806700002477
FCF margin (%): -320.5997438816164
Rule of 40 score: -320.5997438816164
Financial ratios for BKKT — annual report dated 2023-12-31
Total revenue: 726988000
Gross profit: 8477000
Operating income: -110933000
Net income: -74854000
Capital expenditures: 9433000
Operating cash flow: -60697000
Depreciation & amortization: 13932000
Net tangible assets: -22619000
Owner earnings: -70355000
Buffett classification: The Gruesome
Stock price: 55.75
Shares outstanding: 44706924
Book value: 135714000
P/B ratio: 18.365172443520933
Market cap (USD): 2492411013
Debt to equity: 0.20013410554548536
Current ratio: 1.8015479814560575
Quick ratio: 1.8015479814560575
COGS to revenue (%): 98.83395599377155
SG&A to revenue (%): 13.62237065811265
Free cash flow (dilution-adjusted): -86891000
Buyback yield (%): 0.10568080409938392
Retained earnings: -751301000
Receivables turnover: 24.507416396979504
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -67.3165729126844
FCF margin (%): -11.952191783083077
Revenue growth (%): 1193.0207740466703
Rule of 40 score: 1181.0685822635874
Financial ratios for BKKT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.57
Shares outstanding: 44706924
Market cap (USD): 427845262.68
Buyback yield (%): 0.026177688470461948
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BKKT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.77
Shares outstanding: 44706924
Market cap (USD): 1107390507.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BKKT — annual report dated 2024-12-31
Total revenue: 3441056000
Gross profit: 37849000
Operating income: -73520000
Net income: -46659000
Capital expenditures: 3087000
Operating cash flow: -21203000
Depreciation & amortization: 343000
Net tangible assets: -37007000
Owner earnings: -49403000
Buffett classification: The Gruesome
Stock price: 24.77
Shares outstanding: 44706924
Book value: 62853000
P/B ratio: 17.61873749033459
Market cap (USD): 1107390507.48
Debt to equity: 0.3165640462666858
Current ratio: 1.3349283686346836
Quick ratio: 1.3349283686346836
COGS to revenue (%): 98.90007602317428
SG&A to revenue (%): 2.510043428528917
Free cash flow (dilution-adjusted): -40131000
Buyback yield (%): 0
Retained earnings: -797960000
Receivables turnover: 534.2425089271852
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -55.84165033647784
FCF margin (%): -1.1662408283968644
Revenue growth (%): 373.3305088942321
Rule of 40 score: 372.16426806583524
Financial ratios for BKKT — quarterly report dated 2025-03-31
Total revenue: 1065756000
Gross profit: 11121000
Operating income: -15209000
Net income: 16239000
Capital expenditures: 130000
Operating cash flow: -101281000
Depreciation & amortization: 220000
Net tangible assets: -26842000
Owner earnings: 16329000
Return on net tangible assets (%): -60.83376797556069
Buffett classification: The Gruesome
Stock price: 8.67
P/E ratio: 5.9672552355440605
Shares outstanding: 44706924
Book value: 81559000
P/B ratio: 4.752498572567099
Market cap (USD): 387609031.08
Debt to equity: 0.28069250481246705
Current ratio: 1.583291971177709
Quick ratio: 1.583291971177709
Effective tax rate (%): 0.2520965169522046
COGS to revenue (%): 98.9565153750014
SG&A to revenue (%): 1.727318448125087
Free cash flow (dilution-adjusted): -104754000
Buyback yield (%): 0
Retained earnings: -790250000
Receivables turnover: 39.4739064409793
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.897836650582178
FCF margin (%): -9.829079076261358
Rule of 40 score: -9.829079076261358
Financial ratios for BKKT — quarterly report dated 2025-06-30
Total revenue: 577882000
Gross profit: 16808000
Operating income: -18489000
Net income: -14734000
Capital expenditures: 19000
Operating cash flow: 5352000
Depreciation & amortization: 154000
Net tangible assets: -32264000
Owner earnings: -14599000
Buffett classification: The Gruesome
Stock price: 13.95
P/E ratio: 414.393082923588
Shares outstanding: 44706924
Book value: 57825000
P/B ratio: 10.785327968871595
Market cap (USD): 623661589.8
Debt to equity: 0.680086467790748
Current ratio: 1.1853163361661945
Quick ratio: 1.1853163361661945
COGS to revenue (%): 97.09144773500472
SG&A to revenue (%): 5.3097345132743365
Free cash flow (dilution-adjusted): -1005000
Buyback yield (%): 0
Retained earnings: -804984000
Receivables turnover: 26.587623648493214
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.071048397078847
FCF margin (%): -0.17391093683485556
Revenue growth (%): -45.77726984412943
Rule of 40 score: -45.951180780964286
Financial ratios for BKKT — quarterly report dated 2025-09-30
Total revenue: 402211000
Gross profit: 5396000
Operating income: -19676000
Net income: -14918000
Capital expenditures: 3204000
Operating cash flow: -46657000
Depreciation & amortization: 153000
Net tangible assets: 44186000
Owner earnings: -17969000
Return on net tangible assets (%): -40.666727017607386
Buffett classification: The Gruesome
Stock price: 33.65
Shares outstanding: 44706924
Book value: 128564000
P/B ratio: 11.701471583024796
Market cap (USD): 1504387992.6
Debt to equity: 0.09733673501135622
Current ratio: 2.2403533240353326
Quick ratio: 2.2403533240353326
Interest coverage ratio: -393.52
COGS to revenue (%): 98.65841560772827
SG&A to revenue (%): 5.18857017833923
Free cash flow (dilution-adjusted): -57977000
Buyback yield (%): 0
Retained earnings: -819902000
Receivables turnover: 38.86096618357488
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.622127568011658
FCF margin (%): -14.41457344528121
Revenue growth (%): -30.39911262160787
Rule of 40 score: -44.813686066889076
Financial ratios for BKKT — quarterly report dated 2025-12-31
Total revenue: 299173000
Gross profit: 3307000
Operating income: -90710000
Net income: -85270000
Capital expenditures: 464000
Operating cash flow: -10813000
Depreciation & amortization: 80000
Net tangible assets: 42574000
Owner earnings: -85654000
Return on net tangible assets (%): -201.1885188142998
Buffett classification: The Gruesome
Stock price: 10.04
Shares outstanding: 44706924
Book value: 112782000
P/B ratio: 3.979868391764643
Market cap (USD): 448857516.96
Debt to equity: 0.004867798052880779
Current ratio: 2.1858916136845292
Quick ratio: 2.1858916136845292
COGS to revenue (%): 98.89461950109134
SG&A to revenue (%): 21.55074154419015
Free cash flow (dilution-adjusted): -65083000
Buyback yield (%): 0
Retained earnings: -905172000
Receivables turnover: 20.751404591801347
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -69.90705775366452
FCF margin (%): -21.754302694427636
Revenue growth (%): -25.617897073923885
Rule of 40 score: -47.37219976835152
Financial ratios for BKKT — annual report dated 2025-12-31
Total revenue: 2335243000
Gross profit: 26853000
Operating income: -141714000
Net income: -107212000
Capital expenditures: 3817000
Operating cash flow: -153399000
Depreciation & amortization: 607000
Net tangible assets: 42574000
Owner earnings: -110422000
Return on net tangible assets (%): -259.3648705782872
Buffett classification: The Gruesome
Stock price: 10.04
Shares outstanding: 44706924
Book value: 112782000
P/B ratio: 3.979868391764643
Market cap (USD): 448857516.96
Debt to equity: 0.004867798052880779
Current ratio: 2.1858916136845292
Quick ratio: 2.1858916136845292
COGS to revenue (%): 98.85009825529934
SG&A to revenue (%): 5.248490199949213
Free cash flow (dilution-adjusted): -228819000
Buyback yield (%): 0
Retained earnings: -905172000
Receivables turnover: 161.97842824443364
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -109.2140754327286
FCF margin (%): -9.798509191548803
Revenue growth (%): -32.13586178196461
Rule of 40 score: -41.93437097351341
Financial ratios for BLX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.03
Shares outstanding: 30060446
Market cap (USD): 391687611.38
Buyback yield (%): 15.338498909457135
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLX — annual report dated 2022-12-31
Total revenue: 146136000
Net income: 92040000
Capital expenditures: 1651000
Operating cash flow: -769653000
Depreciation & amortization: 2715000
Net tangible assets: 1067243000
Owner earnings: 93104000
Return on net tangible assets (%): 8.723786429145003
Buffett classification: The Gruesome
Stock price: 13.59
P/E ratio: 4.438520872881356
Shares outstanding: 30060446
Book value: 1069347000
P/B ratio: 0.3820289028163917
Market cap (USD): 408521461.14
Debt to equity: 4.145759982493989
COGS to revenue (%): 0
SG&A to revenue (%): 31.083374390978268
Free cash flow (dilution-adjusted): -774531000
Buyback yield (%): 0
Retained earnings: 543612000
Receivables turnover: 2.0388130083569345
Capitalized R&D asset: 0
FCF margin (%): -530.0069797996387
Rule of 40 score: -530.0069797996387
Financial ratios for BLX — annual report dated 2023-12-31
Total revenue: 237335000
Net income: 166158000
Capital expenditures: 2096000
Operating cash flow: 1062114000
Depreciation & amortization: 3094000
Net tangible assets: 1201219000
Owner earnings: 167156000
Return on net tangible assets (%): 13.915530806622273
Buffett classification: The Gruesome
Stock price: 21.83
P/E ratio: 3.9493706964455515
Shares outstanding: 30060446
Book value: 1203824000
P/B ratio: 0.5451125215812278
Market cap (USD): 656219536.18
Debt to equity: 3.6290147064687197
COGS to revenue (%): 0
SG&A to revenue (%): 25.601786504308254
Free cash flow (dilution-adjusted): 1054547000
Buyback yield (%): 0
Retained earnings: 673281000
Receivables turnover: 2.054332678375127
Capitalized R&D asset: 0
FCF margin (%): 444.32848083932
Revenue growth (%): 62.406936004817425
Rule of 40 score: 506.7354168441374
Financial ratios for BLX — annual report dated 2024-12-31
Total revenue: 284779000
Net income: 205873000
Capital expenditures: 3935000
Operating cash flow: -122659000
Depreciation & amortization: 3563000
Net tangible assets: 1333546000
Owner earnings: 205501000
Return on net tangible assets (%): 15.410117086324732
Buffett classification: The Gruesome
Stock price: 33.56
P/E ratio: 4.90024708320178
Shares outstanding: 30060446
Book value: 1337209000
P/B ratio: 0.7544284908043545
Market cap (USD): 1008828567.7600001
Debt to equity: 3.2963822409212025
COGS to revenue (%): 0
SG&A to revenue (%): 23.790377801733975
Free cash flow (dilution-adjusted): -134091000
Buyback yield (%): 0
Retained earnings: 792005000
Receivables turnover: 2.3549662192893233
Capitalized R&D asset: 0
FCF margin (%): -47.08598597508946
Revenue growth (%): 19.99030905681842
Rule of 40 score: -27.09567691827104
Financial ratios for BLX — quarterly report dated 2024-12-31
Capital expenditures: 1676000
Buffett classification: The Gruesome
Stock price: 33.56
Shares outstanding: 30060446
Market cap (USD): 1008828567.7600001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLX — quarterly report dated 2025-03-31
Total revenue: 78023000
Net income: 51732000
Capital expenditures: 223000
Operating cash flow: 196568000
Depreciation & amortization: 1019000
Net tangible assets: 1367246000
Owner earnings: 52528000
Return on net tangible assets (%): 3.841883611288678
Buffett classification: The Gruesome
Stock price: 35.08
P/E ratio: 5.096074217505605
Shares outstanding: 30060446
Book value: 1370671000
P/B ratio: 0.7693461419115163
Market cap (USD): 1054520445.68
Debt to equity: 2.9351697088506286
COGS to revenue (%): 0
SG&A to revenue (%): 17.86396319034131
Free cash flow (dilution-adjusted): 194391000
Buyback yield (%): 0
Retained earnings: 820542000
Receivables turnover: 0.6143785188393244
Capitalized R&D asset: 0
FCF margin (%): 249.14576471040593
Rule of 40 score: 249.14576471040593
Financial ratios for BLX — quarterly report dated 2025-06-30
Total revenue: 90042000
Net income: 64184000
Capital expenditures: 925000
Operating cash flow: 874828000
Depreciation & amortization: 1069000
Net tangible assets: 1412018000
Owner earnings: 64328000
Return on net tangible assets (%): 4.555749289315009
Buffett classification: The Gruesome
Stock price: 39.24
P/E ratio: 4.594493569425402
Shares outstanding: 30060446
Book value: 1415480000
P/B ratio: 0.8333370312826744
Market cap (USD): 1179571901.04
Debt to equity: 2.68323536892079
COGS to revenue (%): 0
SG&A to revenue (%): 13.753581661891118
Free cash flow (dilution-adjusted): 871485000
Buyback yield (%): 0
Retained earnings: 861430000
Receivables turnover: 0.8555953591349215
Capitalized R&D asset: 0
FCF margin (%): 967.8649963350435
Revenue growth (%): 15.404432026453737
Rule of 40 score: 983.2694283614973
Financial ratios for BLX — quarterly report dated 2025-09-30
Total revenue: 82777000
Net income: 54968000
Capital expenditures: 980000
Operating cash flow: 308556000
Depreciation & amortization: 1052000
Net tangible assets: 1634920000
Owner earnings: 55040000
Return on net tangible assets (%): 3.3665255792332345
Buffett classification: The Gruesome
Stock price: 44.76
P/E ratio: 7.8737948723110405
Shares outstanding: 30060446
Book value: 1646473000
P/B ratio: 0.8172047540166162
Market cap (USD): 1345505562.96
Debt to equity: 2.0745411555488613
COGS to revenue (%): 0
SG&A to revenue (%): 15.94162629715984
Free cash flow (dilution-adjusted): 306604000
Buyback yield (%): 0
Retained earnings: 891325000
Receivables turnover: 0.7635409364277017
Capitalized R&D asset: 0
FCF margin (%): 370.39757420539524
Revenue growth (%): -8.068456942315807
Rule of 40 score: 362.3291172630794
Financial ratios for BLX — annual report dated 2025-12-31
Total revenue: 315756000
Net income: 226882000
Capital expenditures: 2796000
Operating cash flow: 780242000
Depreciation & amortization: 4832000
Net tangible assets: 1668003000
Owner earnings: 228918000
Return on net tangible assets (%): 13.724076035834468
Buffett classification: The Gruesome
Stock price: 43.42
P/E ratio: 5.752878436015198
Shares outstanding: 30060446
Book value: 1678747000
P/B ratio: 0.777499268990503
Market cap (USD): 1305224565.32
Debt to equity: 2.4118095222210374
COGS to revenue (%): 0
SG&A to revenue (%): 23.55489681906282
Free cash flow (dilution-adjusted): 769261000
Buyback yield (%): 0
Retained earnings: 916429000
Receivables turnover: 3.3484554449145802
Capitalized R&D asset: 0
FCF margin (%): 243.62514093160544
Revenue growth (%): 10.877557685082117
Rule of 40 score: 254.50269861668755
Financial ratios for BLX — quarterly report dated 2025-12-31
Total revenue: 64988000
Net income: 55998000
Capital expenditures: 1368000
Operating cash flow: -599710000
Depreciation & amortization: 1692000
Net tangible assets: 1668003000
Owner earnings: 56322000
Return on net tangible assets (%): 3.376612631991669
Buffett classification: The Gruesome
Stock price: 43.42
P/E ratio: 5.752878436015198
Shares outstanding: 30060446
Book value: 1678747000
P/B ratio: 0.777499268990503
Market cap (USD): 1305224565.32
Debt to equity: 2.4118095222210374
COGS to revenue (%): 0
SG&A to revenue (%): 53.637594632855304
Free cash flow (dilution-adjusted): -603219000
Buyback yield (%): 0
Retained earnings: 916429000
Receivables turnover: 0.6891695564109905
Capitalized R&D asset: 0
FCF margin (%): -928.200590878316
Revenue growth (%): -21.490269036084904
Rule of 40 score: -949.6908599144009
Financial ratios for BLZR — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -162761
Net income: 2495666
Capital expenditures: 0
Operating cash flow: -80128
Owner earnings: 2495666
Buffett classification: The Gruesome
Stock price: 10.01
P/E ratio: 27.57530454796435
Shares outstanding: 27500000
Market cap (USD): 275275000
Free cash flow (dilution-adjusted): -80128
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLZR — annual report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 267729111
Buffett classification: The Gruesome
Stock price: 10.01
Shares outstanding: 27500000
Book value: 267729111
P/B ratio: 1.0281847908575021
Market cap (USD): 275275000
Debt to equity: 0
Current ratio: 10.33102251621102
Quick ratio: 10.33102251621102
Buyback yield (%): 0
Retained earnings: -10506615
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNBX — annual report dated 2021-09-30
Capital expenditures: 0
Depreciation & amortization: 844438
Buffett classification: The Gruesome
Stock price: 80850
Shares outstanding: 7197228
Market cap (USD): 581895883800
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNBX — annual report dated 2022-09-30
Total revenue: 18168677
Gross profit: 5053640
Operating income: -13969763
Net income: -8267891
Capital expenditures: 489553
Operating cash flow: -8976706
Depreciation & amortization: 1290480
Net tangible assets: 12911829
Owner earnings: -7466964
Return on net tangible assets (%): -57.83041271689704
Buffett classification: The Gruesome
Stock price: 16950
Shares outstanding: 7197228
Book value: 12908939
P/B ratio: 9450.274309918112
Market cap (USD): 121993014600
Debt to equity: 0
Current ratio: 4.765032585415458
Quick ratio: 4.621137799177504
COGS to revenue (%): 72.18487620204817
R&D to revenue (%): 21.608854623812178
SG&A to revenue (%): 83.09553854691785
Free cash flow (dilution-adjusted): -11984924
Buyback yield (%): 0
Retained earnings: -292500088
Inventory turnover: 21.77694920995477
Receivables turnover: 5.922874129922831
Capitalized R&D asset: 3926043
ROCI (R&D-adjusted, %): -51.58810732546606
FCF margin (%): -65.96475901905241
Rule of 40 score: -65.96475901905241
Financial ratios for BNBX — annual report dated 2023-09-30
Total revenue: 13367443
Gross profit: 5533432
Operating income: -10953290
Net income: -9947059
Capital expenditures: 33448
Operating cash flow: -6217677
Depreciation & amortization: 1362249
Net tangible assets: 2252184
Owner earnings: -8618258
Return on net tangible assets (%): -382.66225139686634
Buffett classification: The Gruesome
Stock price: 18150
Shares outstanding: 7197228
Book value: 4872412
P/B ratio: 26810.066184879273
Market cap (USD): 130629688200
Debt to equity: 0.2540343468491581
Current ratio: 2.856016737066325
Quick ratio: 2.7400314399872636
COGS to revenue (%): 58.605157321411426
R&D to revenue (%): 27.941604089877174
SG&A to revenue (%): 95.39329249430875
Free cash flow (dilution-adjusted): -7330014
Buyback yield (%): 0
Retained earnings: -302447147
Inventory turnover: 23.737485114854238
Receivables turnover: 52.31834975851461
Capitalized R&D asset: 6365526.8100000005
ROCI (R&D-adjusted, %): -56.90717158081491
Rosenberg metric: 0.12220752549067852
FCF margin (%): -54.83482517935554
Revenue growth (%): -26.425886706005063
Rule of 40 score: -81.2607118853606
Financial ratios for BNBX — annual report dated 2024-09-30
Total revenue: 2113490
Gross profit: 974840
Operating income: -13668447
Net income: -6992521
Capital expenditures: 407904
Operating cash flow: -13711410
Depreciation & amortization: 432595
Net tangible assets: 6443642
Owner earnings: -6967830
Return on net tangible assets (%): -108.13496466749703
Buffett classification: The Gruesome
Stock price: 487.5
Shares outstanding: 7197228
Book value: 8968085
P/B ratio: 391.2372206552458
Market cap (USD): 3508648650
Debt to equity: 0.08242127499906614
Current ratio: 3.355819382150381
Quick ratio: 3.1753762524373217
COGS to revenue (%): 53.87534362594572
R&D to revenue (%): 170.03865644029543
SG&A to revenue (%): 522.8099967352578
Free cash flow (dilution-adjusted): -14691607
Buyback yield (%): 0
Retained earnings: -309672755
Inventory turnover: 2.631347853717719
Receivables turnover: 6.438620328284367
Capitalized R&D asset: 7391846.45
ROCI (R&D-adjusted, %): -77.75125324618317
Rosenberg metric: -1.2204810716134977
FCF margin (%): -695.1349190201988
Revenue growth (%): -84.18927239861804
Rule of 40 score: -779.3241914188169
Financial ratios for BNBX — quarterly report dated 2024-09-30
Capital expenditures: 371250
Buffett classification: The Gruesome
Stock price: 487.5
Shares outstanding: 7197228
Market cap (USD): 3508648650
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNBX — quarterly report dated 2024-12-31
Capital expenditures: 116879
Buffett classification: The Gruesome
Stock price: 150
Shares outstanding: 7197228
Market cap (USD): 1079584200
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNBX — quarterly report dated 2025-03-31
Total revenue: 762822
Gross profit: 395518
Operating income: -3377544
Net income: -3304175
Capital expenditures: 185319
Operating cash flow: -3185035
Depreciation & amortization: 95062
Net tangible assets: 7761011
Owner earnings: -3394432
Return on net tangible assets (%): -43.736982205024574
Buffett classification: The Gruesome
Stock price: 24.9
Shares outstanding: 7197228
Book value: 10224208
P/B ratio: 17.528103614480454
Market cap (USD): 179210977.2
Debt to equity: 0.04620308976499696
Current ratio: 4.450402601906876
Quick ratio: 4.266236710811311
COGS to revenue (%): 48.150682596988545
R&D to revenue (%): 111.34419300964052
SG&A to revenue (%): 383.2747351282475
Free cash flow (dilution-adjusted): -3396865
Buyback yield (%): 0
Retained earnings: -354442994
Inventory turnover: 1.052851238011156
Receivables turnover: 1.1057202121506855
Capitalized R&D asset: 849358
ROCI (R&D-adjusted, %): -23.445679677675127
FCF margin (%): -445.30244277170823
Rule of 40 score: -445.30244277170823
Financial ratios for BNBX — quarterly report dated 2025-06-30
Total revenue: 304393
Gross profit: 5130
Operating income: -3694060
Net income: -3945363
Capital expenditures: 10923
Operating cash flow: -2816258
Depreciation & amortization: 125573
Net tangible assets: 4563593
Owner earnings: -3830713
Return on net tangible assets (%): -83.94072389891035
Buffett classification: The Gruesome
Stock price: 5.15
Shares outstanding: 7197228
Book value: 6988044
P/B ratio: 5.304162967491333
Market cap (USD): 37065724.2
Debt to equity: 0.04785359107641566
Current ratio: 2.7647409575826636
Quick ratio: 2.5983707931393543
COGS to revenue (%): 98.31467872125837
R&D to revenue (%): 252.4903660728072
SG&A to revenue (%): 962.7773963264594
Free cash flow (dilution-adjusted): -2852070
Buyback yield (%): 0
Retained earnings: -373888601
Inventory turnover: 0.8835036298096084
Receivables turnover: 1.5292518852331358
Capitalized R&D asset: 1337632.8599999999
ROCI (R&D-adjusted, %): -37.512417447902536
Rosenberg metric: -0.4596271536854895
FCF margin (%): -936.9696412203959
Revenue growth (%): -60.09645762707421
Rule of 40 score: -997.0660988474701
Financial ratios for BNBX — annual report dated 2025-09-30
Total revenue: 2136935
Gross profit: 838907
Operating income: -16046595
Net income: -15160724
Capital expenditures: 313121
Operating cash flow: -12518695
Depreciation & amortization: 384165
Net tangible assets: 2304747
Owner earnings: -15089680
Return on net tangible assets (%): -654.7217547088683
Buffett classification: The Gruesome
Stock price: 3.88
Shares outstanding: 7197228
Book value: 1941693
P/B ratio: 14.38190519304545
Market cap (USD): 27925244.64
Debt to equity: 0.09952654719360887
Current ratio: 0.9084849249830859
Quick ratio: 0.8743513868804514
COGS to revenue (%): 60.74251205581827
R&D to revenue (%): 281.5673850631863
SG&A to revenue (%): 508.6064854569746
Free cash flow (dilution-adjusted): -12933837
Buyback yield (%): 0
Retained earnings: -379160375
Inventory turnover: 15.433973032745952
Receivables turnover: 9.001411120471777
Capitalized R&D asset: 9657300.24
ROCI (R&D-adjusted, %): -124.48176700410683
Rosenberg metric: -0.037824834782608695
FCF margin (%): -605.251774153168
Revenue growth (%): 1.109302622676237
Rule of 40 score: -604.1424715304918
Financial ratios for BNBX — quarterly report dated 2025-09-30
Total revenue: 199429
Gross profit: -167980
Operating income: -5996949
Net income: -5271774
Capital expenditures: 0
Operating cash flow: -3191328
Depreciation & amortization: 128564
Net tangible assets: 2304747
Owner earnings: -5143210
Return on net tangible assets (%): -223.15724893014286
Buffett classification: The Gruesome
Stock price: 3.88
Shares outstanding: 7197228
Book value: 1941693
P/B ratio: 14.38190519304545
Market cap (USD): 27925244.64
Debt to equity: 0.09952654719360887
Current ratio: 0.9084849249830859
Quick ratio: 0.8743513868804514
COGS to revenue (%): 184.23047801473206
R&D to revenue (%): 1696.834963821711
SG&A to revenue (%): 1225.994213479484
Free cash flow (dilution-adjusted): -3212976
Buyback yield (%): 0
Retained earnings: -379160375
Inventory turnover: 4.368611923616561
Receivables turnover: 0.8400547598989048
Capitalized R&D asset: 4179206.35
ROCI (R&D-adjusted, %): -69.5669117475945
Rosenberg metric: -0.22523852956751755
FCF margin (%): -1611.0876552557552
Revenue growth (%): -34.48305315825265
Rule of 40 score: -1645.5707084140079